Back to
Connor, Clark & Lunn Investment Management Ltd.
QNCX2 quarters
Position history for
Connor, Clark & Lunn Investment Management Ltd.'s holdings in QUINCE THERAPEUTICS INC
Connor, Clark & Lunn Investment Management Ltd. previously held 0 shares of QNCX (QUINCE THERAPEUTICS INC), worth $0 as of 2022-Q4.
Final Value
$0
Final Shares
0
Total Value Change
-$23,000
Total Shares Change
-17,275
Quarter-by-Quarter History
Other major holders of QNCX: BNP PARIBAS FINANCIAL MARKETS, Capital World Investors, Capital International Investors, Capital Research Global Investors